Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSL-109 in Newborns With Symptomatic Congenital CMV
NCT00004642Phase 2Completed
- Sponsor
- National Center for Research Resources
- Start
- Feb 1995
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of sevirumab in congenital cytomegalovirus infection (cCMV), sponsored by National Center for Research Resources. Started Feb 1995; status: completed.
02
Drugs
sevirumab
03
Conditions
congenital cytomegalovirus infection (cCMV)
Beyond the preview
Go deeper on NCT00004642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004642.